Cerenome, Inc. (CNSY) vs Satellos Bioscience Inc. (MSLE)
A side-by-side comparison of Cerenome, Inc. and Satellos Bioscience Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSY
Cerenome, Inc.
$1.57HealthcareDelayed quote: Oct 6, 2026, 10:53 AM EDT
MSLE
Satellos Bioscience Inc.
$8.11HealthcareDelayed quote: Oct 6, 2026, 10:54 AM EDT
Total return — CNSY vs MSLE
growth of $100 · dividends reinvested · last 1yCNSY -61.5% (-61.5%/yr)MSLE -2.7% (-2.7%/yr)MSLE compounded faster over this window
CNSY MSLE
CNSY vs MSLE: by the numbers
- •CNSY is the larger company ($11M vs $10M market cap).
- •Both run net losses; MSLE's is the smaller (0.00% vs -620.70% net margin).
Metrics side by side
Valuation
| Metric | CNSY | MSLE |
|---|---|---|
| P/S ratio | 2.57 | N/A |
| P/B ratio | 1.98 | 0.17 |
Profitability
| Metric | CNSY | MSLE |
|---|---|---|
| Gross margin | 89.58% | 0.00% |
| Operating margin | -293.46% | 0.00% |
| Net margin | -620.70% | 0.00% |
| ROE | -477.54% | -57.34% |
| ROIC | -479.39% | -59.35% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.